The Hill Ledger

US-listed stock · XLO

Xilio Therapeutics, Inc. (XLO): trades by Congress and insiders

In the last 12 months, company insiders filed 1 open-market buy.

Congress trades
012 months
Members trading
012 months
Insider buys / sales
1 / 012 months
Last close
$8.714 Nov 2026
One-year change
−22.4%

7 disclosed buys and sales on record since 19 December 2024. Insider counts are open-market trades only: awards, option exercises and tax withholding are left out.

Latest disclosures

DisclosedFiled byTypeAmountTraded
GILEAD SCIENCES, INC.Company insider Buy $2M
GILEAD SCIENCES, INC.Company insider Buy Not stated
GILEAD SCIENCES, INC.Company insider Buy Not stated
GILEAD SCIENCES, INC.Company insider Buy Not stated
GILEAD SCIENCES, INC.Company insider Buy Not stated
GILEAD SCIENCES, INC.Company insider Buy $6.3M
GILEAD SCIENCES, INC.Company insider Buy $1.8M